Tanja Lovgren
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Pleiotropic effects of BET inhibition broadly boost tumor immunogenicity to CD8+ T cells.
Journal: Oncoimmunology
Published: April 30, 2026
Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 17, 2025
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.
Journal: Nature communications
Published: September 17, 2025
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling.
Journal: Journal of cellular and molecular medicine
Published: July 25, 2023
Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: May 19, 2023
Immunostimulatory gene therapy targeting CD40, 4-1BB and IL-2R activates DCs and stimulates antigen-specific T-cell and NK-cell responses in melanoma models.
Journal: Journal of translational medicine
Published: May 11, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 20, 2023
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: June 17, 2022
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition.
Journal: Molecular therapy oncolytics
Published: September 03, 2021
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.
Journal: Cancer immunology, immunotherapy : CII
Published: October 08, 2020
Complete and long-lasting clinical responses in immune checkpoint inhibitor-resistant, metastasized melanoma treated with adoptive T cell transfer combined with DC vaccination.
Journal: Oncoimmunology
Published: September 14, 2020
Last Updated: 09/26/2026